Search

everythinglearnresearchcommunity

for

Search:↓

AIRE protein, defective in APECED patients, is found in skin and hair cells and interacts with cytokeratin 17.

Alopecia patients have less GPER-1, which might affect hair loss.

Retinoids increase steroid sulfatase activity in leukemia cells through RARα/RXR and involves certain pathways like phosphoinositide 3-kinase and ERK-MAP kinase.

IVIG therapy significantly improved symptoms in a patient with APS-2 and SPS.

RSPO1 could help create new diabetes treatments by increasing pancreatic β cells.

A Korean boy's skin and digestive symptoms were caused by a rare genetic disorder that affects zinc absorption, and he got better with zinc supplements.

Possible link between hair loss and metabolic syndrome, with RANTES as a potential clue.

GLP-1 receptor analogs may help improve metabolism and reproductive health in people with PCOS and obesity.

Repaglinide-loaded liponiosomal hybrids improve blood sugar control and insulin release better than regular Repaglinide.

Certain gene variations in EGF and EGFR may increase the risk of alopecia areata in Koreans.

Two specific genetic markers increase the risk of hair loss in Asian populations.

Anti-SRP myopathy can be linked to systemic lupus erythematosus and may improve with specific treatment.

OG6, a sugar-based material, can stimulate hair growth.

Extracellular ATP promotes growth, while adenosine inhibits it in Arabidopsis plants.

Certain genetic changes in the LSS gene cause a rare skin and hair condition.

The engineered yeast strain BLYAS can quickly and sensitively detect androgenic chemicals.

Early recognition and a team approach are crucial for managing diffuse alveolar hemorrhage in antiphospholipid syndrome.

High TSPEAR levels in colorectal cancer predict worse outcomes.

Targeting the AhR pathway may help treat alopecia areata.

Alopecia areata involves specific T-cells, unlike androgenetic alopecia.

G allele of AR Stul polymorphism linked to higher hair loss risk, especially in white people.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

Metformin and liraglutide improved symptoms of HAIR-AN syndrome in a child.

AL136131.3 slows hair growth by affecting energy processes in hair loss.

PPAR-γ may be a key target for treating alopecia areata and other skin conditions.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with fewer side effects.

Squaric acid dibutylester can cause severe skin reactions in people with allergies.

Asparagus racemosus root extract reduced sebum and pore size in men but not in women.

Lysophospholipids like LPA and S1P are important for hair growth, immune responses, and vascular development, and could be targeted for treating diseases.

dAR-6–1 is a promising new treatment for hair loss that works better than minoxidil.